Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

Abstract

An amendment to this paper has been published and can be accessed via the original article.

View correction statement:

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

This article refers to:

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

The original article can be found online at https://doi.org/10.1186/s40545-020-00219-1.

Correction to: J Pharm Policy Pract (2020) 13:18

https://doi.org/10.1186/s40545-020-00219-1

Following publication of the original article [1], we notified of a mistake in the article’s title.

Correct article title:

Amid COVID-19: the importance of developing a positive reporting culture of adverse drug reaction (ADR) and medical device incident (MDI) for Global Health and public safety